Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

New treatments for tic disorders.

Qasaymeh MM, Mink JW.

Curr Treat Options Neurol. 2006 Nov;8(6):465-73.

PMID:
17032567
2.

Tourette syndrome: clinical characteristics and current management strategies.

Kossoff EH, Singer HS.

Paediatr Drugs. 2001;3(5):355-63. Review.

PMID:
11393328
3.

Pharmacological options for the treatment of Tourette's disorder.

Jiménez-Jiménez FJ, García-Ruiz PJ.

Drugs. 2001;61(15):2207-20. Review.

PMID:
11772131
4.

Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.

Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA.

J Clin Psychiatry. 2001 Jan;62(1):50-6.

PMID:
11235929
5.
6.

Tourette's Syndrome in Children.

Swain JE, Leckman JF.

Curr Treat Options Neurol. 2003 Jul;5(4):299-308.

PMID:
12791197
7.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

8.

Treatment of tics and tourette syndrome.

Singer HS.

Curr Treat Options Neurol. 2010 Nov;12(6):539-61. doi: 10.1007/s11940-010-0095-4.

PMID:
20848326
9.

Emerging drugs in Tourette syndrome.

Silay YS, Jankovic J.

Expert Opin Emerg Drugs. 2005 May;10(2):365-80. Review.

PMID:
15934872
10.

Pharmacologic treatment of tic disorders.

Scahill L, Chappell PB, King RA, Leckman JF.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):99-117. Review.

PMID:
10674192
11.

Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.

Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K.

Clin Ther. 2008 Jan;30(1):182-9. doi: 10.1016/j.clinthera.2008.01.010.

PMID:
18343255
12.

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.

Arch Gen Psychiatry. 1994 Apr;51(4):302-8.

PMID:
8161290
13.

Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.

Egolf A, Coffey BJ.

Drugs Today (Barc). 2014 Feb;50(2):159-79. doi: 10.1358/dot.2014.50.2.2097801. Review.

PMID:
24619591
14.

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1140-6.

PMID:
7559307
15.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
16.
17.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
18.
19.

Drug and non-drug treatments of children with ADHD and tic disorders.

Poncin Y, Sukhodolsky DG, McGuire J, Scahill L.

Eur Child Adolesc Psychiatry. 2007 Jun;16 Suppl 1:78-88. doi: 10.1007/s00787-007-1010-8. Review. Erratum in: Eur Child Adolesc Psychiatry. 2007 Dec;16(8):537.

PMID:
17665286
20.

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.

Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S.

J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):330-6.

PMID:
11886028

Supplemental Content

Support Center